Pre-patients | Controls | |
---|---|---|
Number (% female) | 71 (80.3) | 276 (80.1) |
Age (range), years | 48.6 (19.6 to 66.9) | 50.0 (18.6 to 69.1) |
Smoking ever, n (%) | 49 (69.0)*** | 122/271 (45.0) |
HLA-SE alleles, n (%) | 38/68 (55.9)** | 39/116 (33.6) |
PTPN22 1858T, n (%) | 28 (39.4)** | 47/210 (22.4) |
Anti-CCP2 antibodiesE (%) | 23 (32.4)*** | 4 (1.5) |
IgM RF, n (%) | 17 (22.4)*** | 14 (5.1) |
IgA RF, n (%) | 28 (36.8)*** | 12 (4.3) |
IgG RF, n (%) | 15 (19.7)*** | 14 (5.1) |